These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12693734)

  • 1. Will endothelin receptor antagonists have a role in heart failure?
    Spieker LE; Lüscher TF
    Med Clin North Am; 2003 Mar; 87(2):459-74. PubMed ID: 12693734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
    Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
    J Am Coll Cardiol; 2001 May; 37(6):1493-505. PubMed ID: 11345356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin receptor blockade in congestive heart failure.
    Cheng TO
    Circulation; 2001 Oct; 104(18):E96. PubMed ID: 11684644
    [No Abstract]   [Full Text] [Related]  

  • 4. Small-molecule endothelin receptor antagonists: a review of patenting activity across therapeutic areas.
    Mucke HA
    IDrugs; 2009 Jun; 12(6):366-75. PubMed ID: 19517317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.
    Suresh DP; Lamba S; Abraham WT
    J Card Fail; 2000 Dec; 6(4):359-68. PubMed ID: 11145761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelins: pathophysiology and treatment implications in chronic heart failure.
    Teerlink JR
    Curr Heart Fail Rep; 2005 Dec; 2(4):191-7. PubMed ID: 16332312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer and Vascular Effect of Endothelin Receptor Antagonists in the Human Placenta.
    Hitzerd E; Neuman RI; Broekhuizen M; Simons SHP; Schoenmakers S; Reiss IKM; Koch BCP; van den Meiracker AH; Versmissen J; Visser W; Danser AHJ
    Hypertension; 2020 Mar; 75(3):877-884. PubMed ID: 31884859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-receptor blockade improves endothelial vasomotor dysfunction in heart failure.
    Bauersachs J; Fraccarollo D; Galuppo P; Widder J; Ertl G
    Cardiovasc Res; 2000 Jul; 47(1):142-9. PubMed ID: 10869540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETA and ETB receptor antagonists synergistically increase extracellular endothelin-1 levels in primary rat astrocyte cultures.
    Hasselblatt M; Kamrowski-Kruck H; Jensen N; Schilling L; Kratzin H; Sirén AL; Ehrenreich H
    Brain Res; 1998 Mar; 785(2):253-61. PubMed ID: 9518640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin and heart failure.
    Nambi P; Clozel M; Feuerstein G
    Heart Fail Rev; 2001 Dec; 6(4):335-40. PubMed ID: 11447308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and perspective of endothelin-1 antagonism in acute heart failure.
    Kiowski W; Suetsch G; Oechslin E; Schalcher C; Brunner-Larocca HP; Bertel O
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S53-7. PubMed ID: 11811379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin receptor antagonists in pulmonary arterial hypertension.
    Dupuis J; Hoeper MM
    Eur Respir J; 2008 Feb; 31(2):407-15. PubMed ID: 18238950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bosentan and the endothelin system in congestive heart failure.
    Ellahham SH; Charlon V; Abassi Z; Calis KA; Choucair WK
    Clin Cardiol; 2000 Nov; 23(11):803-7. PubMed ID: 11097125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
    Vergouwen MD; Algra A; Rinkel GJ
    Stroke; 2012 Oct; 43(10):2671-6. PubMed ID: 22871682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective and mixed endothelin receptor antagonism in cardiovascular disease.
    Dhaun N; Pollock DM; Goddard J; Webb DJ
    Trends Pharmacol Sci; 2007 Nov; 28(11):573-9. PubMed ID: 17950470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin antagonists and heart failure.
    Hürlimann D; Enseleit F; Noll G; Lüscher TF; Ruschitzka F
    Curr Hypertens Rep; 2002 Feb; 4(1):85-92. PubMed ID: 11790297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin receptor antagonists for pulmonary arterial hypertension: rationale and place in therapy.
    Price LC; Howard LS
    Am J Cardiovasc Drugs; 2008; 8(3):171-85. PubMed ID: 18533738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
    Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
    Teerlink JR; Löffler BM; Hess P; Maire JP; Clozel M; Clozel JP
    Circulation; 1994 Nov; 90(5):2510-8. PubMed ID: 7955209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 and unstable angina: effect of either endothelin ET(A) or ET(B) receptor antagonism in a locally injured canine coronary artery.
    Kirchengast M; Hergenröder S; Schult S; Münter K; Rübsamen K
    Eur J Pharmacol; 1998 Jan; 341(2-3):187-90. PubMed ID: 9543239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.